These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32779325)

  • 1. Sequential Protocol Biopsies Post-Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat?
    Croome KP; Livingston D; Croome S; Keaveny AP; Taner CB; Nakhleh R
    Liver Transpl; 2021 Feb; 27(2):248-256. PubMed ID: 32779325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
    Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
    Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis.
    Croome KP; Mathur AK; Mao S; Aqel B; Piatt J; Senada P; Heimbach JK; Moss A; Rosen CB; Taner CB
    Am J Transplant; 2020 Sep; 20(9):2449-2456. PubMed ID: 32216008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5.
    Han S; Kwon JH; Lee KW; Lee S; Choi GS; Kim JM; Ko JS; Gwak MS; Kim GS; Ha SY; Joh JW
    Sci Rep; 2023 Aug; 13(1):12914. PubMed ID: 37558742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic macrosteatosis in the US pediatric deceased liver donor population.
    Purvis JW; Orandi BJ; Dhall D; McLeod C; Gutierrez Sanchez LH; Gray M; Frey K; Sheikh SS; Cannon RM; Terrault NA; Lewis CE; Locke JE
    Pediatr Transplant; 2022 Feb; 26(1):e14155. PubMed ID: 34590386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A contemporary analysis of 20,086 deceased donor liver biopsies.
    Wang BK; Chen AY; Prasadh J; Desai D; Shubin AD; Raschzok N; MacConmara M; Ivanics T; Cotter T; Hwang C; Shah JA; Mufti A; Vagefi PA; Hanish SI; Patel MS
    World J Surg; 2024 Feb; 48(2):437-445. PubMed ID: 38310313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.
    Núñez K; Hamed M; Fort D; Bruce D; Thevenot P; Cohen A
    World J Transplant; 2020 May; 10(5):117-128. PubMed ID: 32864357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis.
    Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS
    Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Liver Biopsies of Donor Grafts in Pediatric Liver Transplantation: How Do They Fare?
    Guo J; Sanchez-Vivaldi JA; Patel MS; Wang BK; Shubin AD; Kadakia Y; Shah JA; MacConmara M; Hanish S; Vagefi PA; Hwang CS
    Ann Transplant; 2024 Aug; 29():e944245. PubMed ID: 39104079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
    Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A
    Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Extended Criteria Donor Livers in High Acuity Liver Transplant Recipients.
    Guorgui J; Ito T; Younan S; Agopian VG; Dinorcia J; Farmer DG; Busuttil RW; Kaldas FM
    Am Surg; 2021 Dec; 87(10):1684-1689. PubMed ID: 34130521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the hurdles of steatotic grafts in liver transplantation: Insights into survival and prognostic factors.
    Akabane M; Imaoka Y; Esquivel CO; Melcher ML; Kwong A; Sasaki K
    Liver Transpl; 2024 Apr; 30(4):376-385. PubMed ID: 37616509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent outcome following transplantation of a domino donor liver with high-grade macrosteatosis.
    Azabdaftari G; Pomfret EA; Simpson MA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD; Khettry U
    Pathol Res Pract; 2004; 200(7-8):581-7; discussion 589-90. PubMed ID: 15462507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation].
    Yang Y; Dong C; Sun C; Wang K; Zhang W; Zheng WP; Zhang FB; Qin H; Han C; Wang Z; Xu M; Gao W
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):922-929. PubMed ID: 36207981
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome for Pediatric Recipients of Macrosteatotic Liver Grafts From Living Donors.
    Irie R; Nakazawa A; Sakamoto S; Takeda M; Yanagi Y; Shimizu S; Uchida H; Fukuda A; Kasahara M
    Liver Transpl; 2020 Jul; 26(7):899-905. PubMed ID: 32314485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to the rational use of steatotic donor livers in liver transplantation.
    Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
    Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Old donors in liver transplantation for chronic hepatitis C].
    Aguilera V; Ponce M; Berenguer M; Moreno R; Rayón JM; Sanjuán F; Prieto M; Mir J
    Rev Esp Enferm Dig; 2007 Oct; 99(10):581-7. PubMed ID: 18052661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts.
    Jadlowiec C; Smith M; Neville M; Mao S; Abdelwahab D; Reddy K; Moss A; Aqel B; Taner T
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.